Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Clinical trial NCT05053386 · UNKNOWN

Trial details

NCT number: NCT05053386
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2021-10-01
Primary completion: 2022-10-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.